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Abstract
Transgenesis and genome editing in birds are based on a unique germline transmission system using primordial germ
cells (PGCs), which is quite different from the mammalian transgenic and genome editing system. PGCs are progenitor
cells of gametes that can deliver genetic information to the next generation. Since avian PGCs were first discovered in
nineteenth century, there have been numerous efforts to reveal their origin, specification, and unique migration
pattern, and to improve germline transmission efficiency. Recent advances in the isolation and in vitro culture of avian
PGCs with genetic manipulation and genome editing tools enable the development of valuable avian models that
were unavailable before. However, many challenges remain in the production of transgenic and genome-edited birds,
including the precise control of germline transmission, introduction of exogenous genes, and genome editing in PGCs.
Therefore, establishing reliable germline-competent PGCs and applying precise genome editing systems are critical
current issues in the production of avian models. Here, we introduce a historical overview of avian PGCs and their
application, including improved techniques and methodologies in the production of transgenic and genome-edited
birds, and we discuss the future potential applications of transgenic and genome-edited birds to provide opportunities
and benefits for humans.
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Background
The advancement of genetic modification tools and pre-
cise genome editing technologies has created a new era in
which the genotype, phenotype, and traits of animals can
be easily modified. Traditionally, animal breeders used se-
lective breeding or artificial breeding strategies to improve
productivity, food quality, and other traits of offspring
through the selective mating of highly qualified parents
[1]. In terms of the genomic DNA sequence of the desired
animal, this selective breeding strategy is in line with effect
of current genetic modification or genome editing. Thus,
it has become possible to more efficiently improve and
precisely manipulate the genetic traits of animal via recent
genetic modulation technologies in combined with con-
ventional breeding strategy. Currently, the introduction of
genome modulation technology to a targeted animal inev-
itably requires germline modification of that animal,
enabling the transmission of modified genetic traits to
subsequent generations [2]. Germline modification strat-
egies differ among animal species. In mammalian species,
the first transgenic mouse was produced by microinjection
of foreign DNA into the pronucleus of a fertilized oocyte
[3]. The first genetically modified livestock, including rab-
bits, sheep, and pigs, were successfully produced in the
same manner [4]. Even though the efficiency of developing
founder animals is quite low and foreign DNA is ran-
domly integrated into recipient genomes, this strategy is
still a major technological method used in animal trans-
genesis. Another major method in mammalian transgen-
esis, especially in mice, is the use of germline competent
cells like embryonic stem cells (ESCs) for germline modifi-
cation (Fig. 1a). In mammals, germline chimeras that have
a mixture of germ cells originated from both endogenous
and exogenous germ cells can be produced via injection of
genetically modified ESCs into recipient blastocyst [5, 6].
Through the testcross analysis of germline chimera, genet-
ically modified ESC-mediated transgenic offspring can be
generated. However, unlike mammals, birds have a unique
transgenesis and genetic modification system (Fig. 1b) due
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to their oviparity and the physiological properties of the
ovum [7]. Since avian zygote shows discoidal meroblastic
cleavage with a large amount of yolk and a small germinal
disc, it is difficult to introduce foreign DNA into zygote
and microinject avian ESCs into blastoderm [8–10]. The
first transgenic avian specimen was a chicken that was
produced via sub-germinal cavity injection of a retroviral
vector into an Eyal-Giladi and Kochav (EGK) [11] stage X
embryo [12]. Since then, various strategies have been sug-
gested for producing genetically modified transgenic birds,
including viral infection into stage X embryos [13–15],
microinjection of transgenes into fertilized eggs [10, 15],
and embryonic stem cells [16]. However, due to low
germline transmission efficiency, these methods are not
successful in producing genome-modified birds via hom-
ologous recombination until recently. To overcome this
limitation, much effort has focused on the utilization of
primordial germ cells (PGCs) as an alternative strategy
comparable to mammalian germline-competent ESCs
[17]. Here we present an overview of PGCs and recent
progress in transgenesis and genome editing technology,
and introduce potential strategies for PGC-mediated gen-
etic modulation in birds.
Historical overview of avian primordial germ cells
Origin, specification, and development of primordial germ
cells
In late nineteenth century, Waldeyer first observed the ori-
gin of germ cells in the germinal epithelium of chicken em-
bryos [18]. Thereafter, Swift reported that avian PGCs arose
from the endodermal region, the so-called germ wall [19].
Avian PGCs are observed in the epiblast layer and hypoblast
in the central region of the area pellucida of EGK stage X
blastoderm [11, 20, 21]. During early embryogenesis in
chicken (Fig. 2a), PGCs migrate from the central region of
the area pellucida toward the germinal crescent region until
Hamburger and Hamilton (HH) stage 4 [22–24]. After for-
mation of the primitive streak, PGCs are observed in the
germinal crescent region of an extraembryonic site at HH
stages 4–10 [11, 23, 25]. Subsequently, PGCs located at the
anterior region enter the vascular system of extraembryonic
blood vessels via the anterior vitelline vein during HH
stages 10–12 [26, 27], and they start to settle in the gonadal
anlagen at 2.5 d of incubation [28]. On the other hand,
mouse PGCs originate from proximal epiblast and specified
via bone morphogenetic proteins (BMP) signaling derived
from the extraembryonic ectoderm and visceral endoderm
[29]. During mouse embryogenesis (Fig. 2b), PGCs move
from posterior primitive streak to endoderm, and subse-
quently migrate from hindgut endoderm to the mesentery,
and finally settle in the genital ridge [30, 31]. When com-
pared to mouse PGCs, the unique migratory pathway of
avian PGCs enables us to develop PGC-mediated germline
transmission and transgenic system in birds.
PGCs have a large amount of cytoplasmic glycogen gran-
ules. Therefore, periodic acid-Schiff (PAS) staining is con-
ventionally used to identify PGCs in chick embryos [32],
and Eyal-Giladi et al. suggested that PGCs originated from
the epiblast around EGK stage X based on PAS staining re-
sults [33]. Because there were no specific molecular markers
of PGCs or germ plasm, avian species had been assumed to
follow the induction mode of PGC specification [34–36].
However, after the discovery of the chicken vasa homolog
(CVH) gene and the tracing of its expression pattern from
the oocyte through all developmental stages, it was revealed
that avian germline specification is determined by mater-
nally inherited factors, which strongly suggests that avian
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Fig. 1 Transgenic and genome editing system in mammals and birds. a In mammals, transgenic (TG) and genome edited (GE) offspring can be
produced via direct introduction of genome editing tool into the zygote or microinjection of genome edited ESCs into the recipient blastocyst.
b In birds, TG and GE offspring can be produced via injection of genome edited PGCs into the blood vessel of recipient
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Moreover, a recent study on tracing chicken deleted in
azoospermia-like (DAZL) gene in intrauterine-stage chicken
embryos reinforces the evidence for a germ plasm model of
avian PGC origin and specification [38].
Isolation and culture of primordial germ cells
Avian PGCs can usually be isolated at three different de-
velopmental stages, including in the germinal crescent of
HH stage 4–8 embryos, vascular system of HH stage 14–
16 embryos, and gonadal ridge of HH 26–28 embryos. Be-
fore the discovery of PGC cell-surface markers, PGCs
were isolated using a density gradient-dependent centrifu-
gation method [39, 40]. However, the utility of this
method for isolating PGCs was limited due to low yield
rates, purity, and viability after isolation. After the identifi-
cation of PGC-specific surface antigens such as stage-
specific embryonic antigen-1 (SSEA1) in chickens and
quail germ cell-specific marker (QCR1) in quail, it is pos-
sible to collect highly purified avian PGCs using magnetic-
activated cell sorting (MACS) or fluorescence-activated
cell sorting (FACS) systems via PGC-specific antibodies
[41–43]. However, it is still difficult to isolate the PGCs of
wild or endangered birds using such cell sorting methods,
as their PGC-specific surface markers have not yet been
identified. Accordingly, Jung et al. recently developed a
transwell-mediated size-dependent isolation method for
various avian PGCs in HH stage 14–16 embryonic blood,
a strategy based on the size of PGCs [44].
Since the in vitro long-term culture of PGCs was success-
fully established by van der Lavoir in 2006 [45], much effort
has been focused on optimizing PGC culture systems and
cell signaling mechanisms for the in vitro proliferation of
PGCs while maintaining their germline competency. It was
subsequently revealed that basic fibroblast growth factor is
an essential factor for in vitro proliferation and survival via
the MEK/ERK cell signaling pathway [46, 47]. Recently,
Whyte et al. [48] demonstrated that the in vitro self-
renewal of PGCs requires MEK1, AKT, and SMAD3 cell
signaling to maintain germline competency, and Lee et al.
[49] found that Wnt/β-catenin signaling is also required for
the proliferation of PGCs in vitro. In the near future, PGC
culture systems should be developed for multiple bird spe-
cies and optimized for the application of PGC-mediated
avian transgenesis and genome editing.
Production of germline chimeras via primordial germ cells
for avian transgenesis
“Germline chimera” usually refers to the presence of
mixed gametes from different breeds or species in one
individual. For the production of highly efficient trans-
genic birds, much effort has been focused on improving
the efficiency of germline transmission. In 1976, Rey-
naud observed the colonization of germinal crescent-
derived donor turkey PGCs in recipient chicken gonads
after intravascular injection and produced a germline
chimera chicken that produced functional gametes de-
rived from turkey primordial germ cells [50]. PGCs iso-
lated from quail germinal crescent were later
successfully transferred to recipient embryos to produce
quail germline chimeras [51]. Subsequently, the first
transgenic bird was produced using PGCs isolated from
the germinal crescent of HH stage 5 chicken embryos
[52]. As shown in Fig. 3, avian germline chimeras and
donor-derived progeny have been produced by transfer-
ring PGCs isolated from the blood of HH stage 14–16
embryos (bPGCs) [53, 54] and gonads of HH stage 26–
28 embryos (gPGCs) [55, 56] in chicken and quail. As
previously mentioned, density gradient centrifugation
and immunomagnetic cell sorting methods were devel-
oped to obtain purified PGCs and efficiently produce
germline chimeras [39, 42]. In the meantime, germline
chimeras were produced using cryopreserved bPGCs
[57] and gPGCs [58]. Cryopreservation of PGCs can en-
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Fig. 2 Schematic representation of the development and migration of PGCs in mouse and chicken. a Mouse PGCs originated from epiblast, and
migrate through dorsal mesentery to seettle in the genital ridge. b Chicken PGCs located at the center of area pellucida region, and they migrate
through germinal crescent and vascular system to settle in the genital ridge
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restore endangered bird species. Recently, interspecies
germline chimera have been produced for the restor-
ation and preservation of birds via transplantation of
pheasant PGCs [59] and Houbara Bustard PGCs [60]
into chicken or chicken PGCs into guinea fowl. Mean-
while, there are other efforts to produced germline
chimera more efficiently through depletion of endoge-
neous PGCs of recipient embryo. Various methods have
been used to eliminate the endogeneous germ cells in
birds through exposure to gamma ray [61], administra-
tion of busulfan into embryo [62] and removal of blood
from recipient embryos at HH stages 14–15 [57]. In
2010, Nakamura et al., reported that the germline
chimera efficiency of busulfan-treated founder was about
99%, whereas the efficiency of busulfan-untreated
chimera was about 6% [63]. Thus, strategies for deple-
tion of enodogenous PGCs can promote the develop-
ment of transgenic and genome edited birds efficiently.
On the other hand, there have been many effort to de-
velop alternative germline chimera systems without
PGCs, using other germline competent cells including
blastodermal cells [64], embryonic germ cells [65], germ-
line stem cells, and spermatogonial stem cells [66]. How-
ever, their germline transmission efficiency is quite low
compared to PGC-mediated germline chimera system.
Because germline chimeras and genetically modified
chickens can be produced using in vitro cultured PGCs
in chickens [45], the in vitro culture system of PGCs has
been optimized and the germline competency of in vitro
cultured PGCs has subsequently been revealed [46, 47,
67]. Although the germline transmission efficiency was
quite variable, from 0% to about 100% for each PGC
line, PGCs are still regarded as the most optimal
germline-competent cells that can be expanded in vitro
without loss of germline competency. To produce more
efficiently germline chimeras using PGCs, several effort
have been made to enhance the germline competency of
PGCs via optimization of culture condition of PGCs [48,
49, 67–69]. However, the relationship between in vitro
culture of PGC and loss of germline competency is still
unclear, and the systems related in vitro long-term cul-
ture of competent PGC is inadequate at present. In
addition, it may be required to identify best germline
competency-associated marker, which contribute to en-
hance the quality of PGCs. Although there are still chal-
lenges to overcome, the PGC-mediated germline
transmission system is the most efficient way to produce
transgenic and genome-edited birds at present.
Fig. 3 Historical contributions to advancemnet of primordial germ cell-mediated production of germline chimeras and genetic modulation in birds.
PGC, primordial germ cell; bPGC, embryonic blood-derived PGC; gPGC, embryonic gonad-derived PGC; HR, homologous recombination; TALEN,
transcription activator-like effector nuclease; CRISPR/Cas9, clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR associated protein;
HDR, homology-directed repair
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Genetic modification and genome editing in birds
Overview of transgenesis in birds
Prior to the establishment of long-term in vitro PGC cul-
ture systems, the major transgenic technology used in birds
was based on injecting viruses into EGK stage X embryos.
In avian species, the first transgenic chicken was produced
by microinjection of recombinant avian leukosis viruses
into the subgerminal cavity of EGK stage X embryos [12].
Subsequently, Vick et al., successfully produced transgenic
chicken using genetically modified PGCs via retrovirus [52]
In addition, Mizuarai et al., produced transgenic quail using
direct injection of a replication-defective retroviral vector
into the blastodermal stage embryos [70]. Because ran-
domly integrated transgene in genome of transgenic animal
was frequently silenced [13, 70–72], the lentiviral system
was introduced to avian transgenesis as an efficient viral
transduction system. It successfully produced various trans-
genic chickens without any gene silencing [73–76]. Further-
more, Agate et al., produced first green fluorescent protein
(GFP)-expressing transgenic finch using microinjection of
lentivirus into blastodermal stage embryos [77]. Meanwhile,
Shin et al., successfully produced transgenic quails using
gPGCs-mediated germline transmission via lentiviral sys-
tem [78]. Although the efficiency of gPGC-mediated trans-
genesis was similar to blastoderm-mediated transgenesis in
quail, it has been enabled to produce transgenic birds via
viral transfection combined with directly purified PGCs
without cultivation.
On the other hand, there have been many efforts to de-
velop non-viral transgenic systems without PGCs, such as
sperm-mediated gene transfection [79, 80] and direct
microinjection of transgenes into the fertilized eggs [81].
However, these strategies showed low germline transmis-
sion efficiency compared to PGC-mediated transgenesis.
Due to the establishment of long-term in vitro culture sys-
tems, PGC-mediated transgenesis has become a more opti-
mal method for developing genetically modified birds than
the aforementioned methods. Accordingly, a highly efficient
non-viral system for stable genomic integration of trans-
genes into the genome of PGCs was developed using trans-
posable elements, such as piggyBac and Tol2 [82, 83]. The
introduction of transgenes into the genomes of cultured
PGCs using lipofectin or electroporation showed a remark-
ably higher efficiency than the conventional methods for
producing transgenic chickens. More recently, a piggyBac
transposon system with Flipase recombinase recognition se-
quences was developed for introducing site-specific gene
cassette exchange in transgenic chicken genomes via PGCs
[84]. Meanwhile, there have been several efforts to develop
alternative strategies for transgenesis without the use of
PGCs. Although the level of transgenic efficiency is usually
lower than PGC-mediated transgenesis, the transgenic birds
were produced via direct injection of transfection reagents
into circulating PGCs at HH stages 14–16 [85–87]. This
strategy can be applied to produce genetically modified
birds, of which PGCs are difficult to manipulate in vitro.
Precise genome editing technology
In recent years, investigators have successfully developed
efficient systems for precise genome editing using
programmable nucleases, including zinc-finger nucleases
(ZFNs), transcription activator-like effector nucleases
(TALENs), and clustered regularly interspaced short palin-
dromic repeat (CRISPR)-CRISPR associated protein
(CRISPR/Cas). Compared to conventional genetic modifica-
tion technology based on homologous recombination
events, which have extremely low frequency in eukaryotic
cells [88], these programmable nucleases yield a much
higher frequency of homologous recombination events [89]
and also induce targeted mutagenesis through error-prone
non-homologous end-joining (NHEJ) [90]. Because these
programmable nucleases share common features with con-
ventional genetic engineering tools, including DNA double-
strand break repair, gene disruption, gene insertion, gene
correction, and point mutagenesis [91], programmable nu-
cleases are innovative genome editing tools. ZFNs were first
discovered in 1996 and consist of a zinc finger-based DNA
binding domain for DNA recognition and a FokI nuclease
for DNA cleavage [92]. ZFNs have been used in several
organisms for gene editing, including mouse, rat, and zebra-
fish [93, 94], but there are no reports of generating
ZFN-mediated gene-edited birds. As a second generation
programmable nuclease system, TALENs have a similar
protein structure to ZFNs, consisting of a FokI endonucle-
ase and a DNA-binding domain, but they have different
DNA-binding domains known as transcription activator-
like effectors (TALEs), which can be programmed to bind
targeted DNA sequences [95]. Although TALEN-targeted
DNA sequences must start with a thymine base [96], the
TALEN system is much more convenient for determining
target sites than ZFNs. Accordingly, TALENs have been
more widely utilized in various species due to easy
construction, widely applicable possibilities [97, 98], and
lower cytotoxicity than ZFNs [99]. A third generation
programmable nuclease system is based on a CRISPR with
a Cas endonuclease derived from the RNA-based immune
system of prokaryotes against bacteriophages, viruses, or
foreign nucleic acids [100]. In 2012, Jinek et al. reported that
a dual RNA, called a guide RNA (gRNA), consisting of a
20-bp CRISPR RNA (crRNA) and universal trans-activating
crRNA (tracrRNA), together with Streptococcus pyogenes
type II Cas9 protein (Cas9), induced cleavage of specific tar-
get DNA sequences [101]. Thus, Cas9 coupled with dual
RNAs has become a powerful tool for gene editing due to
its target-specific cleavage capacity. In the CRISPR/Cas sys-
tem, the target site selection depends on the protospacer
adjacent motif (PAM) sequence NGG, which has an
important role in the initiation of Cas9 nuclease activity
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[102, 103]. Compared to TALEN, CRISPR/Cas9 is simpler,
easier to use for constructing chimeric single-guide RNA
[104], and has lower cytotoxicity and higher targeting effi-
ciency [105]. To enhance target specificity, avoid breakage
of double-stranded DNA, reduce off-target effects, and in-
crease homology directed repair (HDR) events or base con-
version, various Cas9 variants such as Cas9n [106], Cas9dn
[85], and Cas9 D10A [107] have been developed. In addition
to the Cas9 endonuclease, a class 2-type V CRIPSR effector
endonuclease called CRISPR from Prevotella and Francisella
1(Cpf1) was recently identified [108] which lacks tracrRNA
and utilizes a thymidine-rich PAM recognition sequence, in
contrast to the guanine-rich PAM sequence of the class 2-
type II effector nuclease Cas9. Although it is difficult to dir-
ectly compare the effectiveness of Cpf1 and Cas9 because of
their different PAM sequences, genome-wide analysis shows
that Cpf1 has higher accuracy and specificity and has rela-
tively fewer off-target effects than Cas9 [109, 110]. Re-
searchers should choose and use programmable nucleases
appropriately for their own purposes, optimizing for factors
such as no dsDNA breaks, higher HDR, lower off-target
effects, or precise base conversion.
Generation of genome-edited birds: analysis from the
germline transmission perspective
Despite the importance of avian species as an ideal animal
model of early embryogenesis and organogenesis in devel-
opmental biology [111], it had been difficult to investigate
loss or gain of function in specific genes in birds due to the
lack of precise gene targeting system. Unlike mammalian
species, specific gene-targeted birds could not be success-
fully produced until an in vitro culture system for PGCs
and efficient gene editing technologies were developed (Fig.
3). In 2013, the immunoglobulin gene knockout chicken
was first produced via homologous recombination in
chicken PGCs [112]. The total germline transmission rate
of targeted PGCs is approximately 0.1% because the hom-
ologous recombination event occurs at a very low fre-
quency, as previously discussed. However, with recent
advances in gene editing technology using programmable
nucleases, the ovalbumin gene-targeted chicken was gener-
ated with TALEN in 2014 [113]. Although 8% of the chicks
of the donor PGC-derived offspring were mutants from the
transplantation of an average of 33.3% mutant PGCs,
TALEN-mediated gene knockout showed higher germline
transmission efficiency in mutant progeny than the conven-
tional homologous recombination-mediated gene knockout
system. This is because TALEN-induced NHEJ occurs
much more frequently than homologous recombination in
eukaryotic cells [91]. Subsequently, the CRISPR/Cas9
system-mediated ovomucoid (OVM) gene-targeted chicken
was efficiently produced by transplanting transient
puromycin-selected PGCs into endogenous PGC-ablated
recipient embryos with gamma-ray irradiation [114]. In that
report, the two G0 founders, with the exception of one
founder, had on average 93% mutant semen, indicating that
the CRISPR/Cas9 system induced OVM mutation was
highly efficient in almost all of the donor PGCs. Further-
more, from the testcross analysis of two G0 founders, the
donor PGC-derived offspring were 72%, of which 53% were
OVM gene mutant offspring. Concurrently, Dimitrov et al.
successfully produced CRISPR/Cas9-mediated precise
genome-edited chickens via HDR insertion of an additional
loxP site into the variable region segment segment (VH) of
a loxP previously inserted into the joining gene segment
(JH) of chicken immunoglobulin heavy chain (IgH) locus
[112, 115]. Through Cre recombination of the loxP site
inserted at the IgH locus, an approximately 28-kb genomic
DNA sequence at the IgH locus was deleted. From their re-
sults, germline transmission rates were highly variable for
each PGC line; even a founder from the same PGC line
showed 0–90% efficiency. It is therefore important to use
reliable germline-competent PGC lines for germline trans-
mission of genetically modified or precisely edited genes.
More recently, Tayler et al. successfully produced a CVH
gene-targeted chicken via the TALEN-mediated HDR sys-
tem, which induced GFP transgene integration into the
CVH locus on the Z chromosome [116]. The efficiency of
HDR-mediated GFP transgene knock-in in the CVH locus
was 8.1% in two-week recovered PGCs after two days of
puromycin selection. Although the percentage of GFP-
integrated PGCs used to generate the G0 founder was not
reported, they established stable GFP-knock-in PGCs using
puromycin selection for two weeks. They produced 6%
CVH-targeted offspring from one G0 male founder that
had 10% genomic equivalents in its semen. From the
TALEN and CRISPR-mediated genome editing results, the
germline transmission efficiency of G0 founders vary
among each genome edited PGC lines. In this regards, it is
also important to optimize the conditions for stable PGC
lines while maintaining their germline competency even
after genetic modification and gene editing, because PGC
lines seem to have different germline competencies for each
established cell line and lose their germline competency
during long-term in vitro cultivation and genetic modifica-
tion [67, 68, 117].
Meanwhile, Cooper et al. reported an ideal method for
avian genome editing called sperm transfection-assisted
gene editing, which is based on direct delivery of a CRISPR
gRNA and Cas9 mRNA mixture into spermatozoa [118].
This method shows a targeting efficiency from 0 to 26.6%
mutation in the GFP gene and from 0 to 3% mutation in
the doublesex and mab-3 related transcription factor 1
(DMRT1) gene. Although the efficiency of gene editing and
germline transmission is still low compared to other
current PGC-mediated transgenesis and genome editing
methods, this strategy can be utilized as a potential alterna-
tive for avian transgenesis and genome editing without
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culturing PGCs in birds, of which PGCs is difficult to ma-
nipulate in vitro.
Application of genome editing technology in birds
The chicken genome sequencing project was completed in
2004, and chicken genomic sequences have been available
to the public since that time [119]. Subsequently, the gen-
omic sequences of the zebra finch and turkey have also
been made accessible. [120, 121]. Due to recent next gener-
ation sequencing technologies, the bird 10K genome se-
quencing project has been initiated in 2015. Furthermore,
the Earth BioGenome Project has recently been proposed
to sequence the DNA of all life on Earth, which will covers
the genomic information of 1.5 million species [122]. As
the genomic information of various avian species has been
revealed, it will create infinite possibilities and provide mul-
tiple opportunities to access invaluable genetic information
from birds [123]. Until recently, there was no way to utilize
this valuable avian genetic information in developing
genome-edited birds, because there was no efficient gen-
ome editing system that could be practically used in birds.
The recent progress in genome editing technology in birds
via PGCs has ushered in an innovative era of avian genome
manipulation for the development of invaluable avian
models (Fig. 4). First of all, in chickens, we expect to be able
to create an efficient bioreactor system for producing valu-
able proteins by applying gene editing technology. It is well
known that as potential bioreactors chickens have the key
benefits that egg white protein is easy to purify and they
produce a large amount of egg white protein daily [7, 124].
Although the strategy for developing chickens as bioreac-
tors has focused on the production of target proteins using
the ovalbumin promoter, which is the most powerful pro-
moter of egg white proteins [76, 125], it is possible to dir-
ectly integrate a target protein sequence into the ovalbumin
locus via HDR-mediated gene editing. This HDR-mediated
target protein insertion into the ovalbumin locus could ul-
timately be an ideal bioreactor system producing more than
one grams of target protein from a single egg with low cost.
Genome editing in chickens is also expected to remove or
enhance specific nutrients in the meat and eggs of chickens.
For example, allergen-free chicken meat and eggs can be
developed by knocking out allergen-related genes such as
ovalbumin and ovomucoid [113, 114]. In addition, it is pos-
sible to make double-muscled and muscle hypertrophy
chickens by editing muscle-related genes such as myostatin,
as is well-reported in other livestock [126–128]. Since con-
ventional genetically modified organism (GMO) has foreign
gene or uncontrolled random mutation, there has been
public concern about the safety issue of food derived from
GMO due to unknown allergen reaction or use of antibiotic
resistance genes. On the other hand, genome-edited chick-
ens and other livestock can be produced by controlled pre-
cise genome editing technology similar to mutations in
intrinsic genomic sequences, like natural mutations, rather
than foreign gene insertion as in conventional GMO. Thus,
scientists and educators should convince the public that
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Fig. 4 Strategies for the production of genome-edited birds. Avian PGCs can be isolated from embryonic blood (HH stages 14–16) and embryonic
gonads (HH stage 26–28) by cell-surface antibody-mediated methods, density gradient centrifugation, and size-dependent isolation methods.
Genome-edited birds can be produced by transplanting directly isolated or in vitro cultured PGCs into the blood vessels of recipient embryos
after the introduction of genome editing tools. Avian genome editing systems can be applied to produce various avian models, such as avian
disease resistance models, bioreactor models, and human disease models
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conventional breeding programmed animal via natural mu-
tation [129]. Through the public discussion and social con-
sensus, genome edited animals are expected to be accepted
by the consumers in the near future.
Additionally, birds are more likely to develop ovarian
cancer than other animal model because they lay a large
number of eggs for their lifecycle and have a relatively short
ovulation cycle, therefore birds are considered to be one of
the best animal model for studying human ovarian cancer
[130]. Thus, with precise gene editing in ovarian cancer-
related genes, it may be possible to create avian models
similar to human ovarian cancer and to reveal the genetic
mechanisms of ovarian cancer pathogenesis through gene
editing technology. Although avian genome editing re-
search has been conducted mostly in chickens, it will be
possible to gradually apply it to various other birds in the
near future. Most notably, zebra finches are an exclusive
non-human model organism for investigating the biological
basis of speech learning, and have been widely used for
neurobehavioral research [131]. Zebra finches are also con-
sidered as the novel avian models for human diseases that
cannot be easily studied in other animal models such as
neurological behavior model, Huntington’s disease and
vocal learning model [132–135]. Until recently, transgenic
system in zebra finches usually utilize the virus-mediated
system that directly injects viruses into the embryos [133].
Gene editing technology can be widely applied to reveal the
function and mechanism of invaluable genes in zebra
finches through the development of efficient germline
transmission systems, including PGC-mediated or sperm-
mediated delivery and other reliable strategies. In addition,
we expect that it will be possible to control bird-specific
diseases and develop avian disease-resistant birds through
gene editing of pathogenesis-related genes in birds. In par-
ticular, high-risk infectious poultry diseases such as avian
influenza and Marek’s disease cause serious problems in
various countries and adversely affect the poultry industry.
Although it will be necessary to first understand the disease
mechanisms and host factors of avian viruses [136, 137],
avian gene editing technology is expected to develop avian
disease-resistant birds by eliminating host factors or recep-
tors of avian viruses.
Conclusion
Birds are not only important as a food resource, but also an
ideal animal model for various disciplines such as behav-
ioral science, immunology and developmental biology. Des-
pite of their importance as an experimental model animal,
until a few years ago, there were many challenges and diffi-
culties in transgenesis and gene editing in birds. Recently
developed programmable genome editing tools have facili-
tated a new era of avian models combined with PGC cul-
ture systems. It is expected to create innovative genome
edited avian models, including specific-gene knockout avian
models, allergen-free poultry, human disease model, egg-
based bioreactor and avian disease resistance model.
Although the establishment of germline-competent cell cul-
ture systems has not yet been successful in various birds,
and challenges for developing efficient germline transmis-
sion strategies still remain, it will be possible to develop
such a useful genome-edited avian models in the near fu-
ture by efficiently introducing gene editing tools into the
germline-competent cells of birds. Thus, application of
gene editing technology to avian species will provide far
more possibilities and benefits to humans.
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